Lilie L. Lin
- Obstetrics and Gynecology top 0.5%
- Endometrial and Cervical Cancer Treatments 48
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment 21
- Oncology top 5%
- Viral-associated cancers and disorders 14
- Cancer survivorship and care 11
- PARP inhibition in cancer therapy 10
- Radiation top 5%
- Advanced Radiotherapy Techniques 11
-
- Advances in Oncology and Radiotherapy 11
-
- Cervical Cancer and HPV Research 22
Lilie L. Lin
102 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 111
- Obstetrics and Gynecology 738
- Reproductive Medicine 393
- Oncology 712
- Radiation 214
- Radiology, Nuclear Medicine and Imaging 473
Countries citing papers authored by Lilie L. Lin
This map shows the geographic impact of Lilie L. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilie L. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilie L. Lin more than expected).
Fields of papers citing papers by Lilie L. Lin
This network shows the impact of papers produced by Lilie L. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilie L. Lin. The network helps show where Lilie L. Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lilie L. Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 14 | |
| 9 | 2022 | 3 | |
| 10 | 2021 | 1 | |
| 11 | 2020 | 1 | |
| 12 | 2020 | 26 | |
| 13 | 2017 | 5 | |
| 14 | 2015 | 99 | |
| 15 | 2015 | 20 | |
| 16 | 2014 | 1 | |
| 17 | 2013 | 8 | |
| 18 | 2012 | 16 | |
| 19 | 2012 | 59 | |
| 20 | 2002 | 95 |
About Lilie L. Lin
Lilie L. Lin is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Oncology, having authored 111 papers that have together received 2.1k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (48 papers), Cervical Cancer and HPV Research (22 papers), Ovarian cancer diagnosis and treatment (21 papers), Viral-associated cancers and disorders (14 papers), Advanced Radiotherapy Techniques (11 papers), Advances in Oncology and Radiotherapy (11 papers), Cancer survivorship and care (11 papers) and PARP inhibition in cancer therapy (10 papers). The work is most often cited by research in Obstetrics and Gynecology (738 citations), Reproductive Medicine (393 citations) and Oncology (712 citations). Lilie L. Lin has collaborated with scholars based in United States, Botswana and Canada. Frequent co-authors include Tom R. Miller, Perry W. Grigsby, Emma C. Fields, Nandita Mitra, Mengye Guo, Sasa Mutic, Perry W. Grigsby, Surbhi Grover, Matthew A. Powell and Anuja Jhingran. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.